Semefab has strong 2020 and 2021 outlook is better

23 Dec 2020

Semefab has strong 2020 and 2021 outlook is better

Semefab is planning to grow from £11.9M to £12.9M next year as it implements its strategy to focus on the power semiconductor market and MEMS sensors. 2020 was profitable at 10% and we believe we can lift that to around 12.5% in 2021. 

The raw silicon supply industry is forecasting a compound annual growth rate (CAGR) in demand for substrates of 8.6% annually out to 2025. 
Plimsoll (a UK market analysis company) have rated Semefab’s 2020 performance as "strong" when compared against 453 of the UK's largest companies in the Electronic Component Manufacturing industry.

Read Next